Navigation Links
Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
Date:5/11/2011

harma currently focuses its drug development activities in diseases including C1 esterase inhibitor deficiency and C. difficile infection. ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of its company Web site, www.viropharma.com.

Safe Harbor Statement

In addition to historical information, the statements set forth above include forward-looking statements (including, without limitation, statements concerning the timing and scope of our expected activities under the Halozyme-ViroPharma collaborative partnership) that involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are also identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including regulatory approval requirements and competitive conditions. These and other factors that may result in differences are discussed in greater detail in the company's reports on Forms 10-K, 10-Q, and other filings with the Securities and Exchange Commission.

Halozyme Contact
Robert H. Uhl
Senior Director, Investor Relations
(858) 704-8264
ruhl@halozyme.com


'/>"/>
SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
2. Halozyme Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference on May 12
3. Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6
4. Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
5. Halozyme Therapeutics to Host Fourth Quarter and 2010 Financial Results Conference Call on March 11
6. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
7. Halozyme Therapeutics Realigns Management
8. Halozymes rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
9. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
10. Halozyme Therapeutics to Host Analyst Meeting on October 14 in New York
11. Halozyme Therapeutics Announces Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 ResMed (NYSE: ... patent infringement action against Chinese medical device manufacturer BMC Medical ... ruled today that BMC,s masks listed below infringe ResMed,s patents, ... selling these masks in the United States ... N2 nasal mask , Willow nasal pillows mask ...
(Date:12/24/2014)...   Synageva BioPharma Corp. (NASDAQ: ... products for rare disorders, today announced validation by ... Authorization Application (MAA) for sebelipase alfa for LAL ... for accelerated assessment, which has the potential to ... The MAA, and the Biologics License Application ...
(Date:12/24/2014)... DALLAS , Dec. 23, 2014  Lockton ... operation of Lockton Companies, announced the addition of ... Foerster will join Lockton Dunning,s Pharmacy Consulting team, ... years of relevant industry experience to the position.  ... Managed Market Sales at Diplomat Specialty Pharmacy, where ...
Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3Kim Foerster Joins Lockton Companies 2
... NEW YORK, Sept. 26, 2011 Reportlinker.com ... is available in its catalogue: ... 2011-2021 http://www.reportlinker.com/p0629356/Pharmaceutical-Contract-Manufacturing-World-Market-Outlook-2011-2021.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical ... How will the pharma contract manufacturing ...
... PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: ... M.D., F.A.C.P., to its Board of Directors as a ... of Directors to nine members, seven of whom are ... Vice President and Chief of Medical Affairs at UnitedHealth ...
Cached Medicine Technology:Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 2Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 3Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 4Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 5Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 6Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 7Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 8Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 9Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 10Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021 11Reed V. Tuckson, M.D., Executive Vice President and Chief of Medical Affairs at UnitedHealth Group, Joins Board of Directors of Cell Therapeutics, Inc. (CTI) 2Reed V. Tuckson, M.D., Executive Vice President and Chief of Medical Affairs at UnitedHealth Group, Joins Board of Directors of Cell Therapeutics, Inc. (CTI) 3
(Date:12/25/2014)... Product liability lawsuits filed in the ... http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal court, ... in the U.S. District Court, Northern District of Ohio ... conference on January 7, 2015, at the Paul G. ... Palm Beach, Florida. The Conference is scheduled to begin ...
(Date:12/25/2014)... December 26, 2014 Recently, Dylan Queen, ... has excitedly released its collection of discounted prom dresses, ... Percy, a senior spokesman of the company, the promotion ... this promotion is to expand the UK market. , ... several different colors, lengths, and styles: A-line strapless, empire ...
(Date:12/25/2014)... BambooFlooringChina.com sells many bamboo products and the ... the company announces big discounts on its bamboo ... , BambooFlooringChina.com is the world’s leader in bamboo flooring. ... until Jan. 20, 2015. , The bamboo mats are ... natural thread. All the bamboo strips for the mats ...
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide ... Now, all of the models at LunaDress.co.uk come with big discounts, ... the wedding veil can turn out to be a most exciting ... veil can always bring surprise to a wedding. On the updated ... choose veils for a big day . , Going out ...
(Date:12/25/2014)... THURSDAY, Dec. 25, 2014 (HealthDay News) -- Overeating is common ... you eat in moderation, an expert says. "Don,t arrive ... up calories if you know you,ll be attending a party, ... Jill Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount ... better to eat healthy during the day and even to ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2
... Employment Sectors , ... Brookfield, Wisconsin (PRWEB) November 26, ... looking for help in managing their money. One place they may ... employers conducted by the International Foundation of Employee Benefit Plans ...
... not work unless personal accountability is an integral part. ... instructor, just released his new book, Change Made Easy ... Mental Health, published by Advantage Books in Orlando, Florida. ... without all the hype and product promotions. It is ...
... RARITAN, N.J., Nov. 26 Johnson & Johnson Pharmaceutical ... received a Complete Response letter from the U.S. Food ... (NDA) for ceftobiprole for the treatment of complicated skin ... , , The FDA ...
... Inc.,(NYSE: NUS ) today announced that it will ... 4, 2008, at the Grand Hyatt Hotel,in New York City. ... operational results and introduce 2009 plans. , ... be accessed by visiting the investor,relations section of the company,s ...
... more than 20,000 people will,visit the emergency room due to ... is a odorless and colorless gas which will kill approximately,500 ... Aurora Health Care and the American ... poisoning this holiday season. The,winter months see a drastic increase ...
... With economic pressures on the rise,consumers are looking for ways ... they can for their pets. In the midst of ... visits and,spending for recommended procedures. , ... to become economic casualties.,Through a not-for-profit pet health resource - ...
Cached Medicine News:Health News:43% of Employers Offer Financial Education Programs for Their Employees 2Health News:43% of Employers Offer Financial Education Programs for Their Employees 3Health News:43% of Employers Offer Financial Education Programs for Their Employees 4Health News:Lt. Col. Weinstein, New Book: Universal Health Care Will Not Work Unless 2Health News:Lt. Col. Weinstein, New Book: Universal Health Care Will Not Work Unless 3Health News:Lt. Col. Weinstein, New Book: Universal Health Care Will Not Work Unless 4Health News:FDA Issues Complete Response Letter for Ceftobiprole for Treatment of Complicated Skin Infections 2Health News:FDA Issues Complete Response Letter for Ceftobiprole for Treatment of Complicated Skin Infections 3Health News:'Tis the Season for Carbon Monoxide 2Health News:As Consumers Put a Leash on Spending, Experts Caution Against Being 'Penny Wise and Pound Foolish' with Their Pets 2Health News:As Consumers Put a Leash on Spending, Experts Caution Against Being 'Penny Wise and Pound Foolish' with Their Pets 3Health News:As Consumers Put a Leash on Spending, Experts Caution Against Being 'Penny Wise and Pound Foolish' with Their Pets 4
... Signature is a state of the ... integrates blood, sterile body fluid and ... microbiology workstation with comprehensive capabilities. It ... and where expanded flexibility in operating ...
The Vitek 2 - XL is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat ...
IDS Rapid STR, a microbial identification system....
IDS Rapid NF Plus, a microbial identification system....
Medicine Products: